Academic Haematology Unit, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
McMaster Centre for Transfusion Research, Department of Medicine and Department of Pathology and Molecular Medicine, McMaster University and Canadian Blood Services, Hamilton, ON, Canada.
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. A critical review was performed to identify all relevant articles published between 2009 and 2018. An expert panel screened, reviewed, and graded the studies and formulated the updated consensus recommendations based on the new data. The final document provides consensus recommendations on the diagnosis and management of ITP in adults, during pregnancy, and in children, as well as quality-of-life considerations.
在过去的十年中，免疫性血小板减少症（ITP）患者的治疗实践发生了许多变化和发展。本文是 2010 年发表的国际共识报告的更新版。我们进行了批判性的审查，以确定 2009 年至 2018 年期间发表的所有相关文章。一个专家小组筛选、审查和评估了这些研究，并根据新数据制定了更新的共识建议。最终文件就成人、妊娠期和儿童 ITP 的诊断和管理以及生活质量问题提供了共识建议。
